- Home
- IMVT vs QFIN Comparison
IMVT vs QFIN Comparison
Compare IMVT & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- QFIN
- Stock Information
- Founded
- IMVT 2018
- QFIN 2016
- Country
- IMVT United States
- QFIN China
- Employees
- IMVT N/A
- QFIN N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- QFIN Finance: Consumer Services
- Sector
- IMVT Health Care
- QFIN Finance
- Exchange
- IMVT Nasdaq
- QFIN Nasdaq
- Market Cap
- IMVT 2.7B
- QFIN 3.1B
- IPO Year
- IMVT N/A
- QFIN 2018
- Fundamental
- Price
- IMVT $23.21
- QFIN $22.29
- Analyst Decision
- IMVT Buy
- QFIN Strong Buy
- Analyst Count
- IMVT 9
- QFIN 2
- Target Price
- IMVT $27.71
- QFIN $45.10
- AVG Volume (30 Days)
- IMVT 2.0M
- QFIN 2.2M
- Earning Date
- IMVT 11-10-2025
- QFIN 11-18-2025
- Dividend Yield
- IMVT N/A
- QFIN 6.82%
- EPS Growth
- IMVT N/A
- QFIN 68.82
- EPS
- IMVT N/A
- QFIN 7.06
- Revenue
- IMVT N/A
- QFIN $2,618,582,596.00
- Revenue This Year
- IMVT N/A
- QFIN $17.10
- Revenue Next Year
- IMVT N/A
- QFIN $6.28
- P/E Ratio
- IMVT N/A
- QFIN $3.20
- Revenue Growth
- IMVT N/A
- QFIN 9.77
- 52 Week Low
- IMVT $12.72
- QFIN $20.45
- 52 Week High
- IMVT $31.66
- QFIN $48.94
- Technical
- Relative Strength Index (RSI)
- IMVT 66.40
- QFIN 36.53
- Support Level
- IMVT $23.31
- QFIN $21.12
- Resistance Level
- IMVT $26.17
- QFIN $22.94
- Average True Range (ATR)
- IMVT 1.24
- QFIN 1.40
- MACD
- IMVT 0.19
- QFIN -0.04
- Stochastic Oscillator
- IMVT 61.36
- QFIN 25.30
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About QFIN Qifu Technology Inc.
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.